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Abstract 
 
THE EFFECTS OF REPEATED WHOLE  
BODY WARMING ON SLEEP ARCHITECTURE 
 
Megan M. Clarke 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson:  Caroline J. Smith, Ph.D. 
 
 
 Chronic low back pain (CLBP) is defined as chronic pain in the lower back 
for three or more consecutive months (Buchbinder et al., 2013). In the United States, 
approximately 84% of the population experiences low back pain, resulting in 23% of 
the total population developing CLBP. Altered sleep architecture is often associated 
with CLBP and sleep deficiency with concurring side effects can augment pain, 
further disrupting sleep. Current guidelines outlined by the American College of 
Physicians (ACP) and the American Pain Society (APS) recommend physical 
activity, spinal manipulation, and non-steroidal anti-inflammatory drugs (NSAIDs) or 
acetaminophen for treatment of chronic low back pain. Yet, clinicians are primarily 
prescribing pharmaceuticals as a means of alleviating pain and an increased 
dependence on these medications has been observed. With the increasing diagnosis of 
CLBP in the United States, there are elevated economic and financial burdens 
associated with these medical costs and absenteeism with alternative solutions 
needing investigation to mitigate the reliance on pharmaceuticals. The current study 
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aimed to explore whole body heating as a potential therapy for CLBP. Subjects 
underwent seven consecutive evenings of heating, with completion of the protocol 
two hours prior to sleep latency onset. Pain was assessed via administration of the 
McGill Pain Questionnaire prior to the heating protocol (baseline), pre- and post 
heating on all experimental days and during a 48 hour and two week follow-up. 
Ability to perform specific tasks was assessed via the functional and symptoms scale, 
administered at baseline, prior to and following the seven day heating protocol, and 
during both the follow-up visits. A Sleep Profiler was used throughout the study to 
measure sleep architecture from the frontal cortex of the brain. A repeated measures 
ANOVA showed significant decreases in stage N1 sleep (p < 0.05) and increases in 
N3 sleep (p = 0.001) from baseline to post-treatment. Each subject’s pain perception 
decreased and allowed for greater functional ability. These findings suggest that 
seven consecutive evenings of whole body heating protocol altered sleep architecture 
through the increased amount of restorative stage N3 slow wave, decreased stage N1 
sleep, and decreased pain perception. Only small decrements in pain were observed 
48 hours and two weeks after the cessation of the intervention.  
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Chapter 1 
Introduction 
 
Chronic low back pain, defined as pain persisting or recurring for three or more 
months, is one of the most prevalent health complaints among the United States population 
and is continuing to rise (Buchbinder et al., 2013; Itz, Geurts, van Kleef, & Nelemans, 2013; 
Mafi, McCarthy, Davis, & Landon, 2013). Approximately 84% of the United States 
population will experience low back pain at some point in their lifetime, 23% develop 
chronic low back pain and approximately 11-12% of the population become disabled by this 
condition (Balague, Mannion, Pellise, & Cedraschi, 2012). When chronic low back pain 
develops, nearly 65% of chronic low back pain patients continue to experience symptoms 
twelve months after the onset of pain, which highlights the need for improved pain 
management strategies (Balague et al., 2012; Itz et al., 2013). Considering the increasing 
prevalence of chronic low back pain and subsequent healthcare consumed, alternative 
therapies need to be acknowledged. 
 Physicians have explicit guidelines by the American College of Physicians (ACP) and 
the American Pain Society (APS) outlining care for initial chronic low back pain visits (Haas 
& De Abreu Lourenco, 2015; Mafi et al., 2013). The treatment plan includes: non-steroidal 
anti-inflammatory drugs (NSAIDs) or acetaminophen, a referral for physical therapy, 
increased physical activity, and cognitive relaxation techniques (Haas & De Abreu Lourenco, 
2015; Mafi et al., 2013). However, these are not the most common treatments for chronic low 
back pain. Between 1999 and 2010, the amount of NSAIDs and acetaminophen prescription 
decreased from 36.9% to 24.5% (Mafi et al., 2013). Whilst this may indicate a decrease in 
2 
NSAID use, narcotic prescription increased significantly (p < 0.001) from 19.3% to 29.1% 
(Mafi et al., 2013).  Neurotropic drugs, used to decrease nerve pain, are more widely 
prescribed and have become problematic due to the greater risk for adverse drug reaction 
(Patel, 2015). Similarly, opioids are used to decrease acute pain and are not to be used for 
more than a month. Yet, insurance companies are claiming that patients are still using them 
months to years later (Deyo, Von Korff, & Duhrkoop, 2015). Opioids are highly addictive 
and once patients begin a regimen with opioids they have difficulty ceasing and become 
addicted to the drug-induced state (Martell et al., 2007). Limited data are available on 
pharmacological use in chronic low back pain; however, available data show no significant 
differences between pharmacological treatment and placebo (Balague et al., 2012). 
Clinically, pharmacological treatments are heavily relied on, but do not solve the underlying 
issues associated with chronic low back pain and have deleterious side effects.  
 A common comorbidity of chronic low back pain is disordered sleep and the side 
effects that are associated with altered sleep architecture (Artner et al., 2013). Patients with 
chronic low back pain experience increased onset sleep latency and decreased deep sleep, 
which decreases physical and cognitive functioning, reduces pain thresholds, and lowers 
overall quality of life (Artner et al., 2013). There are four stages of sleep are wakefulness 
(awake), non-rapid eye movement sleep stage 1 (N1), non-rapid eye movement sleep stage 2 
(N2), non-rapid eye movement sleep stage 3 (N3) and rapid eye movement (REM) sleep 
stage (Bajaj & Pachori, 2013). Stage N1 is the transitional sleep stage characterized by 
restlessness. Conversely, stage N3 is the deep, slow wave sleep, which augments restorative 
sleep (Bajaj & Pachori, 2013; Horne & Shackell, 1987). Increased pain perception leads to 
increased frequency of doctor visits and narcotics prescription, causing higher risk of adverse 
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reactions (Patel, 2015). Approximately 55% of all patients suffering from chronic low back 
pain have difficulty falling asleep or staying asleep throughout the night (Bahouq, Allali, 
Rkain, Hmamouchi, & Hajjaj-Hassouni, 2013). Even following a treatment with a sleep 
enhancing pharmaceutical, 42% of patients still experienced insomnia (Artner et al., 2013). 
Patients with lower pain thresholds or unsuccessful pain therapies and surgeries had higher 
perceived pain and were more likely to have decreased sleep quality (Artner et al., 2013). 
Sleep disorders are highly correlated with increased mortality and decreased quality of life 
(Andrew, Derry, Taylor, Straube, & Phillips, 2014). Increased pain and side effects of poor 
sleep quality are often not considered by clinicians, principally due to lack of resources or 
expertise available (Bahouq et al., 2013). Alternative therapies that restore restful sleep 
architecture should be given further consideration to provide patients with treatments for pain 
management (Artner et al., 2013).  
 The growing epidemic of chronic low back pain in adults in the United States 
emphasizes the need for alternative treatments. The current study investigated the effects of 
whole body heating on sleep architecture and pain perception as an alternative method to 
pharmacotherapy. We hypothesized that seven evenings of heating will decrease chronic low 
back pain perception and improve overall sleep architecture.  
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Chapter 2 
Review of Literature 
 
Introduction 
 Chronic low back pain (CLBP) affects millions of Americans each year, resulting in 
billions of dollars spent on healthcare (Balague et al., 2012; Itz et al., 2013). The current 
alternative treatments available have limited guidelines and are not widely used to treat 
CLBP (Chandler, Preece, & Lister, 2002; Nadler, 2004). A reliance on pharmaceuticals has 
inflated these medical costs and alternative methods must be explored in further detail. 
  
Current Treatments for Chronic Low Back Pain 
Current guidelines for chronic low back pain management outlined by the American 
College of Physicians (ACP) and the American Pain Society (APS) suggest inclusion of 
physical activity, spinal manipulation, acupuncture, and cognitive relaxation techniques in 
conjunction with prescription medication, such as non-steroidal anti-inflammatory drugs 
(NSAIDs) or acetaminophen (Haas & De Abreu Lourenco, 2015; Mafi et al., 2013). There is 
a large reliance on pharmaceuticals as treatment for chronic low back pain with little focus 
on alternative treatments.  
 
Pharmacotherapy 
Patients are becoming dependent on pharmacotherapy and are at greater risk for 
developing multiple long-term side effects due to increased pain medication prescriptions 
(Mehra, Hill, Nicholl, & Schadrack, 2012; Patel, 2015). The most highly prescribed 
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medications are NSAIDs, neurotropics, and opioids for long-term treatment of low back pain 
(Lavigne, Nashed, Manzini, & Carra, 2011; Patel, 2015). NSAIDs have the fewest 
unfavorable side effects, which impacts approximately 13% of the prescribed population 
(Patel, 2015), including gastrointestinal distress, vomiting, and potential development of 
cardiovascular problems (Anwar, John Anwar, & Delafontaine, 2015; Patel, 2015). During a 
twelve month observational study comprising 300 subjects, Patel and colleagues observed 
neurotropics to increase drowsiness in 46% of subjects, fatigue in 23%, and dizziness in 19% 
(Patel, 2015). Most medications pose potential side effects, yet and the benefits must 
supersede the associated risks. Opioids are classified as one of the strongest pain 
pharmaceuticals and are increasingly being prescribed for low back pain (Deyo et al., 2015). 
Additionally, opioids have the greatest risk for severe side effects, including addiction (Deyo 
et al., 2015). Opioids are intended for acute care use of one month or less, nevertheless 
insurance companies report significantly longer use in 50% of cases (Deyo et al., 2015; Patel, 
2015) From 1999 – 2010, opioid use for chronic back pain quadrupled and during this time 
period, addiction rehabilitation admissions for opioid use increased at the same rate (Deyo et 
al., 2015). The effectiveness, side effects, and addiction risk of opioids compared to NSAIDs 
or other pharmaceuticals has yet to be determined and many patients become addicted to 
opioids due to inadequate management of their chronic low back pain (Deyo et al., 2015; 
Martell et al., 2007). Approximately 25% of all patients prescribed opioids for chronic low 
back pain have developed addiction to the medication and show signs of drug abuse, but it is 
not recognized until the cessation of the prescription (Deyo et al., 2015; Martell et al., 2007). 
Opioids have also been shown to decrease both deep sleep and rapid eye movement (REM) 
sleep, leading to a greater pain perception associated with poor sleep quality (Lavigne et al., 
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2011). The current pharmacological approach to chronic low back pain management is 
financially inefficient and the long-term physiological effects have not been thoroughly 
investigated.  
 
Local Heat Therapy 
Localized musculoskeletal heating has been widely utilized to decrease pain in many 
conditions, although its effects are confined to the region of application and the effects are 
short lived (Wright & Sluka, 2001). Localized superficial heat is commonly applied to the 
skin’s surface via hot packs, heating pads, or warm water baths (Wellington, 2014). It has 
been noted that the application of superficial heat can reduce acute pain and associated 
muscle spasms (Nadler, 2004). Superficial heat applied to the lower back has however been 
shown to be superior in short-term pain relief over acetaminophen or ibuprofen (Chou & 
Huffman, 2007). For acute low back pain, Nadler, et al., showed that an overnight heating 
wrap could be used to reduce low back pain with limited side effects and safety risks (Nadler, 
Steiner, Petty, et al., 2003). However, this technique has not been investigated in patients 
with CLBP. Localized heat therapy also benefits the patient by stimulating the 
thermoreceptors in the skin and reducing the pain signals to the brain and simultaneously 
increasing range of motion and reducing stiffness (Chandler et al., 2002). In regards to heat 
application to the skin’s surface, clinicians have limited or no guidelines for prescribing 
whole body heating therapy or even local heating protocols (Wellington, 2014). 
Unfortunately, due to the limited guidelines and safety precautions of these methods, local 
heating needs to be carefully monitored (Chandler et al., 2002; Wellington, 2014). Clinically, 
in hospital settings, local heating can be supervised to minimize the risk for burns and heat 
7 
related injury (Chandler et al., 2002). Patients need to be continuously monitoring the 
temperature of the local heating device while at home, since the safety standards are not met 
on these devices (Chandler et al., 2002). Superficial heat application is common practice to 
decrease chronic low back pain, but controlled whole body heat therapy needs further 
investigation in this patient population (Chou & Huffman, 2007; Wright & Sluka, 2001). The 
primary investigation of whole body heating as a therapy for chronic low back pain that has 
been completed thus far shows promise in reducing chronic low back pain (Wellington, 
2014). 
 
Whole Body Heating Therapy 
Whole body heating has been shown to be beneficial in prior investigations; however, 
there are no current guidelines in place for clinical use. Previous studies have used whole 
body heating as a method to alleviate back pain (Kesiktas et al., 2012; Strauss-Blasche et al., 
2002). Subjects showed significant increase in social function, general mental health, energy, 
and general health, while simultaneously observing decreases in physical limitations, body 
pain, and emotional problems (Kesiktas et al., 2012; Strauss-Blasche et al., 2002). 
Limitations of these studies are that the subjects were immersed in water cooler than the 
body’s natural core temperature (Tc) of 37°C (Kesiktas et al., 2012). These studies do not 
consider the age of the person, core body temperature and skin temperature elicited, or length 
of time the subject subjects were exposed to heat and do not account for the physiological 
differences that exist between subjects (Andrew et al., 2014; Horne & Shackell, 1987; 
Kesiktas et al., 2012; Raymann, Swaab, & Van Someren, 2007; Strauss-Blasche et al., 2002). 
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Passive whole body heating, including hydrotherapy, balneotherapy, and spa therapy, 
dates back to classical Greek and Roman times as a type of therapy (Bender et al., 2005; 
Jackson, 1990). A previous study demonstrated that when subjects completed multiple spa 
therapies for three weeks that the overall severe chronic back pain was reduced significantly 
(Strauss-Blasche et al., 2002). Long-term pain reduction was also significantly observed in 
subjects who completed four to six therapies per day for three weeks (Strauss-Blasche et al., 
2002). The limitations of this study included combining therapies together and thus, the 
authors could not determine which therapy decreased the subjects’ pain (Strauss-Blasche et 
al., 2002). These subjects strayed from their typical schedules by including therapies six days 
per week, which may have impacted their perception of pain and confounded significant 
results (Strauss-Blasche et al., 2002). A similar study was conducted in which the subjects 
completed ten sessions of physical therapy or balneotherapy (Kesiktas et al., 2012). The 
subjects who underwent the balneotherapy had significant increases in social function, 
general mental health, energy, and general health, while simultaneously observing decreases 
in physical limitations, body pain, and emotional problems (Kesiktas et al., 2012). 
Limitations of this study are that the subjects who participated in balneotherapy were 
immersed in 36°C water, which is less than the body’s natural core temperature (Tc) of 37°C 
(Kesiktas et al., 2012). Again, this protocol lacks one independent variable and may be due to 
the relaxing atmosphere, the warm water, the minerals added to the water, or the exercise that 
the study design incorporates (Kesiktas et al., 2012). These studies do not consider the age of 
the person, core body temperature and skin temperature elicited, or length of time the subject 
subjects were exposed to heat and do not account for the physiological differences that exist 
between subjects (Horne & Shackell, 1987; Raymann et al., 2007). It is important to account 
9 
for differences in body mass and composition because this may change the response to 
heating. 
Cutaneous whole body heating has been shown to reduce sleep onset latency 
(Raymann, Swaab, & Van Someren, 2005). When there is increased distal temperature, such 
as in the hands and feet, there is a far better sleep quality than when this is not applied. This 
is due to the redistribution of blood flow and a minor decrease in core body temperature, the 
time to sleep onset is decreased and there is greater sleep quality throughout the night 
(Raymann et al., 2005).  
 
Financial Burden and Need for Alternative Therapies  
A majority of Americans will visit a clinician for low back pain; due to the amount of 
consumed healthcare and prescription medication, it is regarded as one of the greatest 
financial burdens nationwide (Balague et al., 2012; Buchbinder et al., 2013). In 2004, the 
estimated direct cost of low back pain was 102.6 billion dollars, which has increased by 12% 
during each subsequent year (Dagenais, Galloway, & Roffey, 2014). Indirect costs, such as 
decreased productivity and work absenteeism, accrue an additional 20 billion dollars 
annually (Mafi et al., 2013). Since 2000, the number of patients who have visited a physician 
for chronic low back pain has remained relatively constant, but physician costs have 
increased significantly (Balague et al., 2012). This financial burden has accumulated due to 
increases in costly prescription pain pharmaceuticals and increased diagnostic tests, such as 
magnetic resonance imaging (MRI) and computerized axial tomography (CT) scans 
(Dagenais et al., 2014; Haas & De Abreu Lourenco, 2015). Once chronic low back pain is 
diagnosed, neurotropic drugs are one of the most widely prescribed drug for treating chronic 
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low back pain and have the lowest cost efficacy (Patel, 2015). Physical therapy referrals 
remained the same in treating low back pain, but new and recurring patients seeking medical 
care from physicians increased from 6.8% in 2000 to 14.0% in 2010, which subsequently 
inflates the cost associated with lower back pain (Mafi et al., 2013). The ACP and APS 
guidelines for treating chronic low back pain do include prescription drugs, but rely more 
heavily on using physical activity and alternative and non-pharmacological therapies to 
manage pain (Balague et al., 2012). 
 
Sleep Architecture and the Effects on Pain 
It is well recognized that sleep can reduce the perception of pain in patients with 
chronic low back pain (Bunnell, Agnew, Horvath, Jopson, & Wills, 1988; Horne & Shackell, 
1987; Lavigne et al., 2011). Chronic low back pain patients often have difficulty falling 
asleep or staying asleep throughout the night, which increases pain perception (Edwards, 
Almeida, Klick, Haythornthwaite, & Smith, 2008). The resulting deleterious cycle of sleep 
deprivation and increased pain is challenging to treat until an intervention can break the cycle 
(Lavigne et al., 2011). However, the sleep-pain cycle cannot be broken until a separate 
intervention is utilized to improve pain (Heffner, France, Trost, Ng, & Pigeon, 2011). 
Typically, clinicians treat the pain without consideration for the associated restorative sleep 
disturbances due to lack of resources or expertise (Bahouq et al., 2013). Limited data are 
currently available investigating how sleep can be altered to decrease pain perception in 
chronic low back patients.   
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Timing of Whole Body Heating and Effects on Sleep 
There is a natural change in body temperatures throughout the day that mandates the 
wake and sleep of the human body (Lack, Gradisar, Van Someren, Wright, & Lushington, 
2008). Whole body heating can be achieved by using a warm water bath or by using a water-
perfused suit and previous studies have demonstrated that correctly timed whole body 
heating can be used as a therapy to increase restorative sleep (Di Nisi, Ehrhart, Galeou, & 
Libert, 1989; Dorsey et al., 1996; Horne & Shackell, 1987; Raymann et al., 2007). Whole 
body heating as a therapy to help increase restorative sleep is being investigated with several 
studies that demonstrate the effects of the whole body heating are largely dependent on 
timing of the therapy (Bunnell et al., 1988; Horne & Shackell, 1987; Raymann et al., 2007). 
Bunnell et al., investigated the best timing for this therapy by using water perfused suits to 
heat subjects for one hour in the morning, afternoon, early evening, and late evening 
(Bunnell et al., 1988). Participants underwent heating on four different days with one heating 
session per day (Bunnell et al., 1988). It was concluded that early evening was the best time 
for the whole body heating therapy because it showed an increase in restorative sleep and a 
decrease in the effects of sleep deprivation (Bunnell et al., 1988). Similarly, Horne and 
colleagues determined that a thirty-minute heat therapy session in the evening approximately 
two hours before sleep onset increased slow wave sleep and REM sleep (Horne & Shackell, 
1987). Di Nisi, et al., experimented with passive body heating of young healthy males in the 
afternoon (Di Nisi et al., 1989). However, due to the extended heating periods of three hours 
from 2pm to 5pm, there were no significant differences. The authors concluded that this time 
of day and length of heating was inappropriate for changing the sleep architecture (Di Nisi et 
al., 1989). Another method that should be explored more is the methods used by Dorsey and 
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colleagues (Dorsey et al., 1996). Passive whole body heating was completed on two 
consecutive evenings using warm baths for thirty minutes (Dorsey et al., 1996). The baths 
lasted for thirty minutes each and the average rise in core temperature was 0.9°C (Dorsey et 
al., 1996). This phenomenon has not been investigated in patients with chronic low back 
pain. 
 
Summary 
There is a growing epidemic of chronic low back pain in adults in the United States. 
Typically, pharmacotherapy is prescribed to reduce this pain, but there are many side effects 
that coincide with this form of treatment. In the present study, the effects of repeated whole 
body heating on sleep onset latency, sleep architecture (slow wave sleep and REM sleep), 
and chronic low back pain will be investigated. In previous studies, whole body heating has 
been achieved via submersion in a warm water bath, often for a set time period (Horne & 
Shackell, 1987; Raymann et al., 2007). Notably, this does not account for variations in 
human physiology between subjects, such as body composition, age, or sex. In the present 
study, a set rise in Tc will be elicited using a water-perfused suit. It has been shown that 
heating approximately two hours prior to sleep onset can improve sleep architecture and 
reduce pain perception (Bunnell et al., 1988; Raymann et al., 2007). Therefore, the purpose 
of this study is to determine if whole body heating will decrease perception of low back pain 
that has persisted for more than one year and improve overall sleep architecture. 
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Chapter 3 
Methodology 
 
Subjects 
 Six subjects aged 30 to 65 years with chronic low back pain for at least one year were 
recruited. The Institutional Review Board (IRB) at Appalachian State University approved 
this study (Appendix A) and the study was verbally explained before all subjects completed 
an informed consent prior to participating in the study. All subjects underwent a physical 
health screening to determine that they were fit to participate in the study (Appendix B). 
Subjects were excluded from the study if they smoked, had known skin conditions, previous 
back surgery, prescribed medications known to alter cardiovascular or thermoregulatory 
control, medications which could alter sleep, were previously diagnosed with 
hypercholesterolemia, hypertension, cardiovascular disease, metabolic disease, or heat 
related illnesses.   
 
Experimental Design 
Each subject arrived at the Thermal and Microvascular Laboratory at Charleston 
Forge for a total of ten visits, as described below. The time of the study was customized to 
each participant to allow a time period of two hours post-heating before the subject’s routine 
sleep latency onset. Follow-up visits were conducted 48-hours and two weeks following the 
completion of the seven day heating protocol. 
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Screening Visit 
 A screening visit was completed to determine if participants were suitable to 
complete the study. The subjects completed an informed consent and were provided with a 
verbal explanation of the study’s objective and experimental procedures. The subject 
completed a BodPod (COSMED USA, Inc., Chicago, IL, USA) test to obtain body 
composition. The results were used to determine if the subject was obese, which is an 
exclusion criterion of the study. Next, baseline pain data were collected via the McGill Pain 
Questionnaire, the Functional Limitation Scale, and the Symptom Scale (Appendix C). 
 
Baseline Sleep Profile 
 At the end of the screening visit, subjects took home an ambulatory sleep monitor: 
Sleep Profiler (Advanced Brain Monitoring, Inc., Carlsbad, CA, USA). Participants resumed 
ordinary evening and sleeping habits to avoid confounding variables. The Sleep Profiler is an 
electroencephalogram (EEG) and electrocardiogram (ECG) device that measures frontal lobe 
brain and heart activity, respectively, while the subjects slept. Baseline data were collected 
using the Sleep Profiler for three nights: two weekday and one weekend nights. 
 
Whole Body Heating Protocol 
 Upon arrival to the laboratory, a urine sample was collected and urine specific gravity 
(USG) was measured using a refractometer (NSG Precision Cells, Inc., Farmingdale, NY, 
USA) to evaluate hydration status. The USG value of 1.02 units or lower was considered 
hydrated and was required for continuation of the protocol. If the USG was above 1.02, 
subjects were required to drink fluids with electrolytes and USG was re-tested until adequate 
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hydration was achieved. Other check-in procedures included measurement of heart rate, 
blood pressure, and sublingual temperature to assure that the subject was well and able to 
complete the protocol. A body weight and separate clothes weight were measured before 
commencing heating to determine the quantity of sweat lost throughout the experiment. Six 
copper-constantan thermocouples were placed on the body to measure skin temperature at the 
following locations: calf, thigh, abdomen, chest, upper arm, and upper back. A water 
perfused suit (Med-Eng, Ottawa, Ontario, Canada) and rain suit were donned by the subject 
and the feet were wrapped for the whole body heating protocol. This technique was used to 
prevent the evaporation of sweat and used to elevated core body temperature. To provide an 
index of core body temperature, a sublingual temperature probe (BIOPAC Systems, Goleta, 
CA, USA) was inserted under the subject’s tongue. Beat-by-beat blood pressure was 
recorded throughout the protocol, including systolic, diastolic, mean arterial pressure (MAP), 
and heart rate (HR) using a Finometer (Finapres Medical Systems, Amsterdam, The 
Netherlands). After baseline values were recorded, whole body heating was initiated via 
perfusion of warm water through the water-perfused suits. The circulating water baths were 
set to 50°C with the temperature of the water being lower as it circulated through the water 
perfused suit. Subjects rested in a supine position until core body temperature has reached a 
0.8°C rise (Figure 1). Core temperature, MAP, BP, HR, and thermal scale were continuously 
recorded throughout the protocol. Subjects were verbally asked to identify a value on the 
thermal scale at each at each 0.1°C rise in core temperature. The thermal scale ranges from 
zero to ten, with zero being very cold and ten being unbearably hot. The thermal scale is a 
subjective way for the participant to objectify his or her thermal threshold. The time of whole 
body heating was dependent on a combination of body composition, age, aerobic fitness, and 
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other individual characteristics, and ranged from approximately thirty to sixty minutes 
between subjects. The test was terminated if HR reached 85% of age predicted maximum, 
due to any erratic changes in BP or HR, or at the request of the subject. After completion of 
the whole body heating protocol, the subject was deinstrumented. This protocol was repeated 
for seven evenings, with completion being two hours prior to the subject’s routine sleep 
latency onset.  
 Sleep architecture was measured each evening following whole body warming using 
the ambulatory Sleep Profiler. 
 
Figure 1. A schematic representation of the whole body heating protocol conducted on seven 
consecutive evenings. 
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Pain Scales 
 As illustrated in Figure 1, the subjects completed the Functional Scale, the Symptoms 
Scale and the McGill Pain Questionnaire. The Functional and Symptoms Scales were 
completed by subjects on days one (prior to heating) and seven (post heating) of heating. The 
McGill Pain Questionnaire was completed prior to and immediately following heating on all 
heating seven heating days. Pain Scales were administered prior to heating to determine the 
effects of the previous night’s sleep on the perception of pain. The McGill pain scales were 
completed immediately post-heating was utilized to determine the effects of heating on pain. 
 
Post-Intervention follow up  
 The subjects returned to the Charleston Forge lab 48 hours and two weeks after the 
last day of heating for a follow up and to complete the McGill Pain Scale, the Functional 
Limitation Scale, and the Symptoms Scale. On both occasions, the ambulatory sleep monitor 
was used to collect sleep data for the night following the 48-hour follow up and the night 
prior to returning to the lab for the two-week follow up. The post-intervention follow up was 
used to assess the rate of decay in the treatment effects.  
 
Data Analysis and Statistics 
Skin temperature (Tsk) signals were digitized at 40 Hz, recorded and stored for 
offline analysis using Windaq software and Dataq data acquisition (Windaq, DataQ 
Instruments, Akron, OH). Core temperature was measured using the BIOPAC sublingual 
probe (BIOPAC Systems, Goleta, CA, USA). The pain data from the McGill Pain 
Questionnaires, Functional Limitation Scale, and the Symptom Scale were analyzed to 
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determine changes in pain perception during the experimental intervention. Sleep data were 
analyzed to determine changes in sleep architecture, including stage N1, N3 and REM. The 
data were analyzed using a within-subject analysis and significance was set at α = 0.05. The 
data were underpowered with six subjects. A repeated measures ANOVA was used to 
determine differences from baseline to the seventh evening of heating for stage N1, N3, and 
REM sleep.  
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Chapter 4 
Results 
Table 1. Subject Characteristics 
Subjects 
(M, F) 
Age, yr Total body 
fat, % 
Systolic 
BP, 
mmHg 
Diastolic 
BP, 
mmHg 
HR, 
bpm 
Height, 
inches 
Weight, 
kg 
(3,3) 49.17 ± 
1.45 
26.6 ± 4.07 126 ± 2.9 79 ± 2.6 66 ± 3.6 67.3 ± 
1.1 
73.6 ± 
3.5 
Values are means ± SE. BP, blood pressure; HR, heart rate. 
Sleep Architecture 
 Significant differences were observed in sleep architecture from baseline to the 
seventh evening of heating (H7) (p < 0.05) and are clinically relevant. Mean absolute times 
for stages N1, N3, and REM (Table 1, Figures 3-4) showed a decrease in N1 and REM and 
an increase in N3 from baseline to H7. A repeated measures ANOVA showed 
significant differences over time for the heating treatment (p < 0.05).  Paired t-tests showed 
significant differences between baseline and time point 7 of the heating therapy (p = 
0.001).  There were no differences between any time points in between days 1-6 of heating 
compared to baseline. Significant decreases were shown from baseline to H7 in stage N1 
sleep time (p < 0.05).  There were no observed differences in REM sleep or overall sleep 
time from baseline to H7.  
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Table 2. Descriptive statistics of mean absolute time ± standard error; p < 0.05*; p < 0.001***. 
 
Sleep Stage Baseline (hours) Heating 1 
(hours) 
Heating 7 
(hours) 
2 week follow 
up (hours) 
N1 0.40 ± 0.09 0.35 ± 0.09 0.34 ± 0.03 0.40 ± 0.06 
N3 0.76 ± 0.35 0.73 ± 0.27 0.82 ± 0.43 0.76 ± 0.38 
REM 1.22 ± 0.14 1.68 ± 0.40 1.38 ± 0.23 1.30 ± 0.22 
 
 
 
Figure 2. Changes in stage N1 sleep (± SE) from baseline to the seventh heating day. Significant 
from baseline; p < 0.05*. 
 
 
 
Figure 3. Changes in stage N3 sleep (± SE) from baseline to the seventh heating day. Significant 
from baseline; p < 0.001***. 
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Figure 4. Changes in REM sleep (± SE) from baseline to the seventh heating day. No significant 
differences were observed in REM sleep. 
 
Pain Perception 
 
 In each subject, pain decreased on the McGill Pain Questionnaire from baseline to 
post heating treatment (H7) and remained lower than baseline during the 48-hour and two 
week follow up visits (Figure 5). This scale ranges from zero points (no pain) to a maximum 
point value of 78 (severe pain). Mean data represent the overall changes in pain and show the 
same decrease in pain after the heating protocol (Figure 6). The Functional Scale was used to 
evaluate the ability of a subject to perform functional tasks on a daily basis (Figure 7). For 
this scale, the more points a subject scores, the lower the functional ability of the subject. For 
each subject, his or her low back pain limited function more at baseline than H7. The score 
on the Functional Scale remained lower than baseline values for all subjects after the 48-hour 
and two week follow up visits. The most limited function score is 168 points and a high 
functioning score is 28 points. The mean data for the Functional Scale show that the sample 
increased functional ability from baseline to H7. After the heating protocol the decline in 
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function was greater than at H7 but remained lower than baseline at both the 48-hour and two 
week follow up visits.   
 
 
Figure 5. The McGill Pain Questionnaire from each subject at baseline, day 7 of heating, and the 48 
hour and two week follow up visits. The McGill Pain Questionnaire ranges from 0 (no pain) to 78 
(severe pain).  
 
 
 
 
Figure 6. The mean data (± SE) McGill Pain Questionnaire quantifies the pain subjects experienced 
from 0 (no pain) to 78 (severe pain). 
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Figure 7. The Functional Scale evaluates the ability of a subject to perform daily tasks and how 
limitations caused by pain. This figure shows the This scale ranges from 28 (no limitations) to 168 
(severely limited). 
 
 
 
 
Figure 8. The Functional Scale mean data (± SE) are represented above. This scale evaluates the 
ability of a subject to perform daily tasks and how limitations caused by pain. This scale ranges from 
28 (no limitations) to 168 (severely limited). 
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Chapter 5 
 
Discussion 
The primary findings of this study are that seven consecutive evenings of whole body 
heating in chronic low back pain sufferers 1) alters sleep architecture with increases in N3 
and reductions in N1 sleep, 2) decreases pain perception following seven consecutive days of 
whole body heating treatment with 50°C water, and 3) only small decrements in pain 
perception and functional ability were observed two weeks following the cessation of the 
protocol.  
The present preliminary sleep data indicate a decrease in Stage 1 (N1) sleep and an 
increase in Stage 3 (N3) sleep from the baseline sleep measures to the seventh evening of 
heating (H7). Slow wave sleep occurs in stage N3 sleep allowing for a more restorative sleep. 
Conversely, the N1 sleep stage is the more active, restless sleep. Slow wave sleep (N3), is 
characterized by the electroencephalogram (EEG) patterns, can increase the production of 
human growth hormone and protein synthesis (Bajaj & Pachori, 2013). Both have shown that 
these are the most active during the N3 sleep stage, which may restore tissue damage (Horne, 
1983). The brain undergoes the most notable increases in restoration and function in stage N3 
only (Horne, 1983). If an individual remains in the N1 sleep stage, the body does not repair 
itself via the aforementioned hormonal and cellular mechanisms (Horne, 1983; Horne & 
Shackell, 1987). By decreasing the amount of time in N1 sleep and increasing the amount of 
time in N3, a beneficial shift from greater restless sleep towards restorative sleep occurs. For 
subjects with chronic pain, more time spent in stage N3 may repair and restore the body and 
reduce pain (Heffner et al., 2011). Cellular physiological benefits of N3 sleep include 
increased energy levels through improved ATP production, increased mitosis for tissue 
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repair, and protein synthesis of the brain (Horne, 1983). Previous research has concluded that 
heating in the early evening at similar time to the present protocol increased stage N3 sleep in 
young, healthy subjects (Bunnell et al., 1988; Horne & Shackell, 1987; Horne & Staff, 1983). 
Limited data are available on sleep architecture and CLBP with the focus primarily on local 
application of heat therapy or cryotherapy (Drez, Faust, & Evans, 1981; Nadler, Steiner, 
Erasala, et al., 2003). By using a dual approach to acutely improve pain with whole body 
heating and indirectly via alterations in sleep architecture and pain perception, there is great 
potential for increased quality of life and to diminish the healthcare burden.  
 CLBP sufferers that are able to improve sleep quality reap multiple physiological 
benefits and may increase their quality of life. It has widely been reported that individuals 
suffering from chronic pain have low sleep quality (Rohrbeck, Jordan, & Croft, 2007).  These 
individuals often have difficulty sleeping due to the pain they experience resulting in a 
deleterious cycle of poor sleep and increased pain perception. The present study used 
repeated whole body heating techniques to induce beneficial effects since the subjects 
reported little to no pain after each evening of heating. No significant decrease in sleep onset 
latency from baseline to H7 in the present study, but this may be due to being statistically 
underpowered, as other studies have shown a significant decrease in sleep latency onset time 
(Raymann et al., 2005, 2007). Overall, there were reductions in time spent in N1 sleep with a 
subsequent shift to greater absolute time spent in N3. Limited data indicate improvements in 
pain with increased sleep quality alone. However, this study illustrated that with the addition 
of the whole body warming therapy, the subjects were able to have more restorative N3 sleep 
in conjunction with the heating protocol.  
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 The McGill Pain Questionnaire allowed subjects to identify their pain through 
descriptive words classifying their pain and quantifying the associated pain producing a 
cumulative score. The Functional Scale rates specific daily tasks and subjects are asked to 
rate from 1 (little to no limitation) to 6 (severely limited). In the present study, all subjects 
showed a reduction in pain and an increase in functional ability from baseline to the seventh 
evening of the heating protocol. Individuals with higher pain at baseline experienced a far 
greater reduction in pain after the seven evening of the heating protocol than subjects who 
indicated mild to moderate pain. The pain perception remained lower than baseline after 
subsequent follow-up visits. The minimal decay in the response to the McGill Pain 
Questionnaire and the Functional Scale two weeks after cessation of heating suggests 
promising potential for mitigating CLBP. Similarly, subjects indicated higher functional 
ability than baseline during the two follow up visits indicating the thermal therapy may be 
beneficial in improving daily functional ability. Previous studies have utilized local heating 
therapy for acute treatment of pain (Abramson, Tuck, Chu, & Agustin, 1964; Lehmann, 
Masock, Warren, & Koblanski, 1970). These studies concluded that local heating is an 
effective treatment for acute reduction in pain (Jette & Jette, 1996), but none of these 
methods have explicit treatment guidelines. Limited data are available for the effects of 
whole body heating techniques on pain perception. Available data are inconclusive and lack 
consistency in their methodological approaches, including change in core temperature, 
heating times, heating methods, pain assessment, and ultimately or pain reduction (Nadler, 
Steiner, Petty, et al., 2003; Wellington, 2014). The present study indicates a reduction in pain 
across all participants with the use of a water perfused suit at 50°C (~46 – 48°C water 
perfusing the suit) to induce a 0.8°C rise in core temperature for seven consecutive evenings.  
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 A reduction in core temperature and an increase in skin temperature are typical before 
sleep latency onset (Horne & Shackell, 1987; Raymann et al., 2005). In the present study, 
core temperature was elevated two hours prior to sleep latency onset to exacerbate this 
decrease in core temperature and induce sleepiness. There are natural changes in core 
temperature throughout the day with the lowest core temperature at typically sleep latency 
onset in healthy individuals (Raymann et al., 2005). Beyond the changes in core temperature 
observed naturally throughout the day, other cellular mechanisms may be involved in 
reducing pain and altering sleep architecture. Whole body inflammatory responses may be 
altered during the consecutive days of whole body heating to 0.8°C rise in core temperature. 
Previously, interleukin-6 (IL-6) has been observed at higher levels in patients with chronic 
pain, which may interfere with sleep architecture (Heffner et al., 2011). There may be an 
association between CLBP, poor sleep quality, and IL-6 inflammatory responses that may be 
investigated in the future (Heffner et al., 2011). An immune response to the heating protocol 
may also be an underlying mechanism for the reduction in pain both acutely and throughout 
the follow up period. These potential mechanisms, in addition to other unknown possibilities, 
may be inducing the reduction of pain perception and the change in sleep architecture.  
 
Limitations 
 One limitation of this study was the small sample size causing the statistics to be 
underpowered. Although nonsignificant trends were apparent in some of the outcome 
measures, more subjects would increase the statistical power. Additional CLBP subjects will 
be recruited at a latter stage. The inclusion of a control group, exposed to 33°C water, will be 
established to eliminate a potential placebo effect. Finally, the present study only included 
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CLBP subjects with nonspecific musculoskeletal causes, preventing this treatment being 
applied to other clinical groups, which may be explored in the future.  
 
Clinical Significance and Future Direction 
 These data suggest promising potential for whole body warming as a 
nonpharmacological, low cost treatment for CLBP. Reduced pain and improved sleep quality 
may potentially reduce the overall economic and financial burden of CLBP sufferers. The use 
of thermal therapy in this population may help reduce prescription of pain medication and 
repeated physician and physical therapy visits. With this protocol, there are specific 
guidelines for individuals to adhere to without the risk of burns or ineffective therapy. Future 
direction of this research may include increasing the sample size to improve the statistical 
power. The addition of a placebo group with thermoneutral water (33°C water perfused suit) 
to examine sleep architecture and pain perception changes allows elimination of a placebo 
effect resulting from the protocol itself. At present, the timing and frequency of this 
consecutive heating protocol has been show to be effective. Adherence to the seven day 
whole body heating to a 0.8°C rise was effective in reducing pain and positively altered sleep 
architecture. Future research could further refine the protocol by reducing the core 
temperature rise and frequency of the heating treatment. The whole body heating therapy can 
be used as a nonpharmacological alternate therapy for treatment of CLBP with minimal risks 
and large benefits to the subject with no contraindications, for example prior heat-related 
illness. These adjustments warrant further investigation and potential expansion to other 
clinical groups. Once a definitive protocol is established, this study may undergo a clinical 
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trial to determine this treatment as a nonpharmacological alternate therapy for reducing pain 
in CLBP patients. 
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Appendix A 
Appalachian State University 
Informed Consent for Participants in 
Research Projects Involving Human Subjects 
 
Title of Study: The Effects of Whole Body Heating on Sleep and Pain  
IRB Study #: 15-0030 
 
Background/Purpose: 
 
You are being asked to participate in a research study that investigates if whole-body heating 
will aid your sleep which may lead to decreases in chronic pain symptoms such as fibromyalgia, 
lower back pain and arthritis. Scott Collier, PhD and Caroline Smith, PhD (Department of Health 
and Exercise Science at Appalachian State University) are conducting this study.    
 
There is some recent evidence that heat used as a therapy shows beneficial effects on pain 
symptoms, which may be the result of a better night’s sleep following the exposure to the 
warming therapy.  “Warming therapy” could show great promise since it proves to be an 
alternative to drug therapies.   
 
The aim of this study is to investigate if whole-body heating will increase an individual’s quality 
of sleep and decrease their pain symptoms.  You may qualify for this study if you presently have 
one or more of the following conditions; fibromyalgia, lower back pain and/or arthritis. 
 
The remainder of this form will explain the study in greater detail.  If you have any questions, 
please ask the study personnel that gave you this form. 
 
 
Study Procedures: 
If you choose to participate, you will one of approximately 20 participants.  You will be asked to 
complete ONE screening visit lasting approximately one hour and SEVEN consecutive days of 
whole body warming, each lasting approximately 1.5 to 2 hours per day. Between visits you 
will be provided with equipment to measure your sleep. Details of what you will be required to 
do for each visit are described below. 
 
Screening Day 1 (1 hour): Subjects will report to the Charleston Forge Laboratory where Dr. 
Caroline Smith and/or Dr. Scott Collier will perform screening procedures, including; manual 
blood pressure, heart rate, height, weight and body composition (Bod pod) testing. The BOD 
POD system determines the quantity of fat in your body as you sit quietly and comfortably in an 
air-tight pod.  You will wear a tight fitting swim suit and swim cap. To ensure privacy, you will 
change into a swim suit in a private dressing room, with testing conducted where no one can 
watch (other than a staff person).  You will first be measured for height and weight, and then 
enter the BOD POD.  You will sit quietly for about 5-10 minutes.  You can push an escape 
button if you feel nervous about sitting in the BOD POD. 
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Subjects will be familiarized with the lab and all the equipment and procedures that will be 
included in their next 2 visits. You will be asked to fill out a pain scale questionnaire and then 
will be outfitted with a Sleep Profiler ambulatory sleep system. This will require wearing a soft 
headband containing a sleep monitor (encephalograph) during your attempted nightly sleep 
episode the evening following your first lab visit. You will report back to the lab for the heating 
protocol and return the sleep system at this time (within 4 days of the familiarization).  
 
During your first visit you will also be provided with instructions of suitable clothing to bring to 
the laboratory for the whole body heating, and will receive instructions for staying hydrated 
before the study.  
 
EXPERIMENTAL PROCEDURES Lab visit 2 through 8 (1.5-2 hours) 
NOTE: Visits 2-8 will be performed on 7 consecutive days and you will be required to do 
the following on each day:  
Subjects may eat a typical days meals prior to arrival at the laboratory. Upon early evening 
arrival (5-9pm) at the laboratory, blood pressure and body temperature will be recorded and you 
will be asked to complete a pain scale questionnaire and give a urine sample for hydration status 
testing. Then, you will recline on a bed while wearing a whole-body heating suit and rain suit. 
You will be outfitted with a Finapres to measure blood pressure and heart rate. This involves 
wearing a small monitor and velcro strap on the middle finger of the right hand. Wires 
(thermocouples) are taped to the skin of the upper arm, back, abdomen, calf, thigh, and chest to 
measure skin temperature. A small plastic-coated wire (thermistor) will be placed under your 
tongue to measure oral temperature. Temperature of the water flowing through the water 
perfused suit is increased to 48°C (118.4°F). Whole body heating is conducted until a 0.8°C 
(1.4°F) rise in oral temperature is achieved (0.8°CΔToral) or until you wish to stop. If you 
experience a bad headache, feel dizzy or nauseous, you should tell the laboratory personnel 
immediately and may request to stop the study. The protocol will involve being heated in the suit 
for ~40-60 minutes. Once a 0.8°C increase in oral temperature is achieved the water temperature 
of the water perfused suit is reduced to decrease oral temperature to the level before the 
experiment. You will be asked to fill out a pain scale questionnaire following the heating 
protocol. Following the questionnaire, you will be outfitted with a Sleep monitor to take home. 
This involves wearing a soft headband containing a sleep monitor (encephalograph) during your 
attempted nightly sleep episode the evening following the lab visit.  
 
EXPERIMENTAL PROCEDURES Lab visit 9 (20 minutes) 
Sleep monitor drop off and questionnaire exam (20 minutes). You will return to the laboratory 
the following morning prior to 11 am to return the device to the study personnel and complete a 
pain questionnaire. 
 
EXPERIMENTAL PROCEDURES Lab visit 10-11 (1 hour) 
Two days following visit 9, you will be asked to report to the laboratory and answer pain scale 
questionnaires and will repeat the sleep protocol the following night. The next day you will be 
asked to report to the laboratory to return the sleep monitor and complete pain questionnaires.  
Your data will immediately be downloaded from the sleep monitor at each visit, and saved to 
password protected computer.  
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Follow-up Lab visit 12-13: (one hour): Two weeks following visit 9, the subjects will report to 
the laboratory and answer a pain scale questionnaire and will repeat the sleep protocol the 
following night. The next day the subject will report to the laboratory to repeat visit nine 
(equipment return). 
 
Risks: 
 
The risks and discomforts involved with participating in this study are: 
 
Whole body heating: Some individuals experience headaches and mild dehydration during whole 
body heating, and mild dizziness when standing following the experiment. Whole body heating 
imposes a cardiovascular stress resulting in an increase in heart rate. Heat-related illness is a 
potential risk of whole body heating, however, core temperature will not exceed ~0.8ºC increase 
and heating (similar to that experienced during intense exercise or being in a sauna) will be 
stopped if any signs of abnormal symptoms are observed (cessation of sweating, arrhythmia, 
nausea, faintness), or you tell us that you are feeling nauseous, light-headed, or otherwise 
uncomfortable.  
Whole body heating may have similar effects to the frequent use of saunas or hot tubs which 
may temporarily lower your sperm count (fertility) throughout the seven consecutive days of 
heating.  Heating will feel similar to spending 30-40 minutes in a hot tub or sauna. 
 
_______ INITIAL  Limited research has suggested temporary reductions in male fertility when 
men are heated, similar to that experienced following a hot shower, hot tub, or in warm 
environments.    
 
________INITIAL  If you are a female and pregnant you will be excluded from the study. If you 
are a female and agree to participate, we will administer a pregnancy test to confirm your 
eligibility to be heated.  
 
 
Finapres and/or manual blood pressure:  The researchers measure blood pressure using a blood 
pressure cuff and stethoscope or a continuous method that places a small cuff on your finger that 
acts the same way as an arm cuff. During the short time the researchers inflate the cuff, your arm 
may feel numb or tingly. 
 
Ambulatory sleep monitoring:  There may be minor risk of discomfort from wearing the blood 
pressure wrist-device and/or soft headband during your attempted nightly sleep.  Both devices 
contain metal, and so there is a minor risk of allergic reaction if your skin reacts to metals. 
 
Tape and adhesive disks:   The tape or adhesive disks could cause a rash on your skin.  During 
screening, please inform us if you are sensitive to tape.  If a disk sticks very strongly, removing 
the disk could cause an abrasion. You could have an allergic reaction to the adhesive remover.  
The reaction could include rash, itching, fever, or breathing problems.  Although rare, it could 
include changes in pulse, and/or blood pressure, convulsions, shock, and/or loss of 
consciousness.  If a bad reaction should occur, medical help will be summoned. 
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Skin Temperature:  We tape wires to your skin at several sites to measure skin temperature.  
There are no risks associated with this measure. 
 
Medical Screening: The staff collects the information in a private and professional manner. You 
may feel shy about being measured.  You may request someone of the same sex to conduct the 
screening. 
Bod Pod: Use of this technique to calculate percent body fat poses no know risks to subjects. 
Some subjects may feel claustrophobic inside the chamber, however, there is a clear window in 
the front of the chamber, and subjects will be supervised at all times by a member of the 
laboratory personnel. 
 
Answering Pain Questionnaires should not pose any risk to you. 
 
 
Benefits: 
You may benefit from the study by gaining information related to your sleep quality during the 
nights you wore the ambulatory sleep devices (information on both total sleep time as well as 
stages of deep, light, and REM sleep).  Society may also benefit by using the findings of this 
study by instigating whole-body heating as a non-pharmalogical approach to increasing sleep 
quality and decreasing chronic pain.   
 
Voluntary Participation: 
Your participation in this study is entirely voluntary and you may refuse to participate or 
discontinue participation at any time without penalty or loss of benefits to which you would 
normally be entitled. Your decision about whether or not to participate in the study will not 
affect your relationship with Appalachian State University.   
 
Questions: 
If you have any questions about the research, or in the event of a research-related injury, please 
contact Scott Collier, PhD at (828) 262-7145, Caroline Smith, PhD (828) 265-8652.  If you have 
any questions about your rights as a research subject, please contact the IRB Administrator at the 
Appalachian State University Institutional Review Board Office at (828) 262-2692, 
irb@appstate.edu. 
 
 
In Case Of Injury: 
In the rare event of an injury during testing, standard emergency procedures will be followed. If 
you get hurt or sick when you are not at the research site, you should call your doctor or call 911 
in an emergency. If your illness or injury could be related to the research, tell the doctors or 
emergency room staff about the research study, the name of the Principal Investigators, and 
provide a copy of this consent form if possible. Call the principal investigators, Scott Collier or 
Caroline Smith as soon as you can. You will be responsible for any costs for medical care not 
paid by your insurance company. No other compensation is offered by Appalachian State 
University. We have no plans to give you money if you are injured. You have not waived any of 
your legal rights by signing this form. 
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Confidentiality of Research Data: 
The information we collect about you in this study will be combined with information from other 
people taking part in the study. When we write up the study to share it with other researchers, we 
will write about the combined information. You will not be identified in any published or 
presented materials. Only the research personnel associated with this study, including the 
Principal Investigator, study coordinator, research assistants, and all other research staff, and the 
Appalachian State University Institutional Review Board (IRB), a committee responsible for 
protecting the rights of research participants, will have access to information that can identify 
you as a participant or the data obtained in this study. Your identity and the personal information 
we collect about you will be kept strictly confidential.   
 
Consent To Participate In Research   
If you have read this form, had the opportunity to ask questions about the research and received 
satisfactory answers, and want to participate, then sign the consent form to give your consent to 
participate and keep a copy for your records.  
 
_________________________________________________Date__________  
Subject signature  
 
 
This research project has been approved on June 11, 2015  by the Institutional Review Board 
(IRB) at Appalachian State University.  This approval will expire on April 19, 2016 unless the 
IRB renews the approval of this research, per university policy. 
 
Should you have any questions about this research or its conduct, you may contact:  
 
Dr. Scott Collier, PhD at (828) 262.7145 or email him at colliersr@appstate.edu  
  Investigators Telephone/e-mail 
 
Dr. Caroline Smith, PhD at (828) 265-8652 or email her at smithcj7@appstate.edu  
  Investigators Telephone/e-mail 
 
Research Protections 
Appalachian State University  
Boone, NC 28608 
irb@appstate.edu 
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Appendix B 
 
Medical History Form 
 
All information given is confidential.  It will enable us to better understand you and your 
health and fitness habits. 
 
Date: ______________ 
 
Age: ______ 
 
Height: ______________   Weight: ________ 
 
Sex:    
 
Health History Questionnaire 
              Yes     No 
Do you ever get chest pains while at rest and /or during exertion?      ____    ____ 
If yes, has a physician diagnosed these pains?                              ____    ____ 
             
Have you ever had a heart attack?           ____    ____                          
If yes, was your heart attack within the last year?                                         ____    ____ 
            
Do	you	have	high	blood	pressure	(i.e.,	a	reading	of	more	than	150	/	100)?	 				____				____																									
If	yes,	is	your	high	blood	pressure	currently		 	 	 	 	 				____				____															
being	treated	by	medication	(e.g.,	“water	pills”)		
	 	 	 	 	 	
Have you ever been diagnosed with high cholesterol?       ____    ____ 
  
Do you lose your balance because of dizziness or do you ever lose      ____    ____ 
consciousness?          
	
Are	you	currently	being	treated	for	any	heart	or	circulatory	condition,	such					____			____														
as	vascular	disease,	stroke,	angina,	hypertension,	congestive	heart	failure,	
poor circulation, valvular heart disease, blood clots, or pulmonary disease?  
    
Have you ever been diagnosed with a spinal problem or do you experience     ____   ____ 
frequent	low	back	pain?	 	 	 	 	 	 	 	 	
 
Has your physician ever specifically told you not to do “heavy” or “hard”     ____   ____ 
exercise?  
          
Do you know of any other reason why you should not do physical activity?  ____   ____ 
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Has your physician ever specifically advised you to avoid the heat?              ____   ____ 
 
                                                                                                             Yes     No 
 
Do you have a history of heat stroke or other heat intolerance?                     ____    ____ 
 
Have you been exposed to high temperatures frequently (~2 weeks)             ____    ____                                                  
in the past 3 months (i.e. vacation in a hot country)?  
If yes, please explain: 
______________________________________________________________________________
_________________________________ 
 
 
Medical History 
Do you have or have you ever had:  (check if yes) 
 
____ heart murmur     _____ arthritis 
____ extra/skipped heart beats   _____ asthma 
____ chest pain or pressure    _____ bronchitis 
____ high blood pressure    _____ cancer 
____ heart attack     _____ diabetes 
____ stroke      _____ emphysema 
____ leg cramps     _____ epilepsy 
____ varicose veins     _____ pneumonia 
____ dizziness/fainting    _____ rheumatic fever 
____ back pain     _____ scarlet fever 
____ shortness of breath    _____ surgery 
____ injuries to back, knees, ankles   _____ joint pain 
 
 
Explanations/Commments/Descriptions:_____________________________________________
__________________________________________________________________ 
 
_________________________                                                                                          __ 
 
 
If you have ever been diagnosed with diabetes has your doctor ever identified the presence of 
peripheral neuropathy? 
______________________________________________________________________________
_________________________________ 
 
 
Do you have a history of rashes, skin disease or disorders of pigmentation, or known skin 
allergies? 
43 
______________________________________________________________________________
_____________________________                                                                  ____ 
 
________________________________________________________________________ 
Other diseases/injuries/allergies/medical problems that we should be aware of: 
______________________________________________________________________________
__________________________________________________________________ 
 
 
Medicines/Drugs/herbal supplements you are now taking (please list dosages): 
______________________________________________________________________________
___________                                                                                          __ 
 
_________________________                                                                                          __                                                                                                                                            
 
_________________________                                                                                          __ 
 
Family History 
 
Please indicate the number of blood relative (mother, father, grandparents, siblings who have 
or have had the following: 
 
 Heart attack or stroke before age 50   _______ 
 Heart attack or stroke after age 50   _______ 
 Congenital heart disease    _______ 
 Heart operations     _______ 
 High blood pressure     _______ 
 Diabetes      _______ 
 Substantially overweight    _______ 
 High cholesterol levels    _______ 
 
Remarks: ___________________________________________________________ 
 
__________________________________________________________________ 
Present Symptoms Review 
 
Do you ever experience any of the following during exercise? 
 
______ Chest pain 
______ Shortness of breath 
______ Heart palpitations 
______ Cough on exertion 
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Health Inventory 
 
Smoking Habits 
 
Do you smoke cigarettes at present?  Yes ______  No _____ 
 If yes, how many per day?  <1/2 pack ______ 1/2 to 1 pack _____ 
      1 - 2 packs ______ >2 packs _____ 
 
Did you smoke cigarettes in the past and quit permanently?  Yes _____  No ______ 
 
 How may years has it been since you quit?      ________ 
 How many packs per day were you smoking before you quit?   ________ 
 How many years did you smoke before you quit?     ________ 
 
 
Female subjects only: 
Are you postmenopausal?   Yes _____  No ______ 
 
When was the date of your last menstrual cycle (approximate if greater than 1 year):  
_________________________ 
 
Have you had a hysterectomy, bilateral oophorectomy, tubal ligation?   Yes _____  No _____ 
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Appendix C 
 
Pain Scales 
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